Diagnostic marker for hepatocellular carcinoma comprising anti-FASN autoantibodies and a diagnostic composition for hepatocellular carcinoma comprising antigens thereof
    1.
    发明授权
    Diagnostic marker for hepatocellular carcinoma comprising anti-FASN autoantibodies and a diagnostic composition for hepatocellular carcinoma comprising antigens thereof 有权
    包括抗FASN自身抗体的肝细胞癌的诊断标记和包含其抗原的肝细胞癌诊断组合物

    公开(公告)号:US08658769B2

    公开(公告)日:2014-02-25

    申请号:US13501426

    申请日:2010-10-01

    IPC分类号: C07K16/00

    摘要: The present invention relates to an autoantibody specifically recognizing the epitope sequence of FASN (fatty acid synthase), more particularly, to the autoantibody or a fragment comprising an antigen-binding site thereof, a diagnostic composition for hepatocellular carcinoma comprising an agent capable of assessing the expression level of the autoantibody, a hybridoma cell line producing the autoantibody, a diagnostic kit for hepatocellular carcinoma comprising the composition, a method for detecting the autoantibody of hepatocellular carcinoma patient using the composition, and a method for screening a therapeutic agent for hepatocellular carcinoma by administering candidate materials for hepatocellular carcinoma treatment to confirm a reduction in the expression level of autoantibody.

    摘要翻译: 本发明涉及特异性识别FASN(脂肪酸合成酶)的表位序列的自身抗体,更具体地,涉及自身抗体或其抗原结合位点的片段,包括能够评估 自身抗体的表达水平,产生自身抗体的杂交瘤细胞系,包含该组合物的肝细胞癌的诊断试剂盒,使用该组合物检测肝细胞癌患者的自身抗体的方法,以及用于筛选肝细胞癌治疗剂的方法 管理候选材料进行肝细胞癌治疗以确认自身抗体表达水平的降低。